
Masoud Toloue, Quanterix CEO
Quanterix closes Akoya deal after competing bid
Quanterix has completed its acquisition of Akoya Biosciences, following interest from a third-party bidder who threatened to torpedo the deal that has a total enterprise …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.